Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study
Abstract Background Chronic obstructive pulmonary disease (COPD) and heart failure (HF) often coexist. Moreover, elderly patients suffering from HF have a higher incidence of COPD, which further complicates their clinical condition. Indacaterol/glycopirronium has shown benefits in the treatment of C...
Main Authors: | Eugenio Roberto Cosentino, Matteo Landolfo, Crescenzio Bentivenga, Luca Spinardi, Daniela Degli Esposti, Arrigo Francesco Cicero, Rinaldo Miceli, Virna Bui, Emanuela Berardi, Claudio Borghi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-018-0986-y |
Similar Items
-
Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
by: Tae Hoon Kim, M.D., Ph.D., et al.
Published: (2019-01-01) -
INFLOW study: a prospective observational study for assessment of indacaterol and other bronchodilators in symptomatic chronic obstructive pulmonary disease patients from Egypt
by: Waleed M. El-Sorougi, et al.
Published: (2017-01-01) -
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population
by: Leif Bjermer, et al.
Published: (2017-12-01) -
The concept of chronic obstructive pulmonary disease clinical control as a decision - making tool in real clinical practice for optimizing of basic pharmacotherapy
by: S N Avdeev, et al.
Published: (2020-01-01) -
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
by: Wedzicha JA, et al.
Published: (2017-01-01)